Otsuka, Click on Therapeutics get FDA clearance for prescription digital therapeutic
Otsuka Prescription drugs and Click on Therapeutics introduced that Rejoyn, a smartphone-based prescription digital therapeutic for main depressive dysfunction (MDD), ...